IlluminOss Nabs $5 Million, Looks For $20 Million More
lluminOss Medical raised $5 million in a new round of equity financing and looks to raise another $20 million, according to an SEC filing posted today.
The offering was made to cover the purchase of the company’s Series AA preferred stock and the exchange of shares of the company’s Series A, B and C1 preferred stocks for junior non-voting preferred stock.
IlluminOss Medical develops and produces a photodynamic bone stabilization system as a treatment for osteoporotic and fragility fractures.
The offering was made to cover the purchase of the company’s Series AA preferred stock and the exchange of shares of the company’s Series A, B and C1 preferred stocks for junior non-voting preferred stock.
IlluminOss Medical develops and produces a photodynamic bone stabilization system as a treatment for osteoporotic and fragility fractures.